Pds Planning, Inc Astrazeneca PLC Transaction History

Pds Planning, Inc

$1.45 Billion
Q4 2025

A detailed history of Pds Planning, Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Pds Planning, Inc holds 11,852 shares of AZN stock, worth $1.06 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

11,852

Previous 11,671 1.55%

Holding current value

$1.06 Million

Previous $895,000 18.32%

% of portfolio

0.07%

Previous 0.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 26, 2026	BUY	$81.15 - $89.4 $14,688 - $16,181	181 Added 1.55%	11,852 $1.06 Million
Q3 2025 Oct 21, 2025	BUY	$68.72 - $82.11 $80,952 - $96,725	1,178 Added 11.23%	11,671 $895,000
Q2 2025 Jul 24, 2025	SELL	$64.87 - $75.0 $15,698 - $18,150	-242 Reduced 2.25%	10,493 $733,000
Q1 2025 Apr 23, 2025	BUY	$65.37 - $77.96 $102,042 - $121,695	1,561 Added 17.02%	10,735 $789,000
Q4 2024 Feb 10, 2025	SELL	$63.2 - $79.58 $10,175 - $12,812	-161 Reduced 1.72%	9,174 $601,000

Q3 2024 Oct 29, 2024	SELL	$76.67 - $87.62 $157,020 - $179,445	-2,048 Reduced 17.99%	9,335 $727,000
Q2 2024 Aug 07, 2024	BUY	$66.81 - $80.83 $47,635 - $57,631	713 Added 6.68%	11,383 $887,000
Q1 2024 May 01, 2024	BUY	$61.03 - $69.57 $17,149 - $19,549	281 Added 2.7%	10,670 $722,000
Q4 2023 Feb 01, 2024	SELL	$61.89 - $69.28 $22,404 - $25,079	-362 Reduced 3.37%	10,389 $699,000
Q3 2023 Oct 20, 2023	BUY	$64.85 - $71.7 $22,373 - $24,736	345 Added 3.32%	10,751 $728,000
Q2 2023 Jul 20, 2023	BUY	$69.91 - $75.81 $22,930 - $24,865	328 Added 3.25%	10,406 $744,000
Q1 2023 May 01, 2023	BUY	$63.15 - $71.6 $169,999 - $192,747	2,692 Added 36.45%	10,078 $699,000
Q4 2022 Jan 26, 2023	BUY	$54.21 - $70.44 $3,794 - $4,930	70 Added 0.96%	7,386 $0
Q3 2022 Nov 02, 2022	SELL	$53.02 - $135.75 $2,651 - $6,787	-50 Reduced 0.68%	7,316 $401,000
Q2 2022 Jul 15, 2022	BUY	$59.26 - $71.14 $53,985 - $64,808	911 Added 14.11%	7,366 $487,000
Q1 2022 Apr 18, 2022	BUY	$55.72 - $67.12 $50,426 - $60,743	905 Added 16.31%	6,455 $428,000
Q4 2021 Jan 25, 2022	SELL	$54.02 - $63.83 $80,975 - $95,681	-1,499 Reduced 21.27%	5,550 $323,000
Q3 2021 Oct 22, 2021	BUY	$55.56 - $60.79 $74,728 - $81,762	1,345 Added 23.58%	7,049 $423,000
Q2 2021 Jul 26, 2021	BUY	$48.42 - $60.18 $57,184 - $71,072	1,181 Added 26.11%	5,704 $342,000
Q1 2021 Apr 20, 2021	BUY	$47.16 - $54.44 $13,204 - $15,243	280 Added 6.6%	4,523 $225,000
Q4 2020 Jan 21, 2021	BUY	$48.52 - $58.02 $16,399 - $19,610	338 Added 8.66%	4,243 $212,000
Q3 2020 Oct 19, 2020	BUY	$53.07 - $61.1 $207,238 - $238,595	3,905 New	3,905 $214,000

Others Institutions Holding AZN

# of Institutions

1,548

Shares Held

503M

Call Options Held

5.54M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pds Planning, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pds Planning, Inc with notifications on news.

Account